MIPOGG vs PedMed
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MIPOGG
This medical tool assists healthcare professionals in identifying pediatric cancer patients (0-18 years) who may have an underlying cancer predisposition syndrome. It offers genetic referral guidelines based on current scientific knowledge, but does not replace clinical judgment or formal genetic counseling.
- Cancer predisposition syndrome identification
- Genetic referral guidelines
- Pediatric cancer patient focus (0-18 years)
- Decision-support tool for clinicians
- Based on current scientific knowledge
- Regularly updated guidelines
Read full descriptionHide full description
Geared towards healthcare providers, researchers, and trainees, the McGill Interactive Pediatric Oncogenetic Guidelines (MIPOGG) app is a decision aid to determine which patients with cancer should be evaluated in genetics. The questions are simple to answer based on the type of tumor with which a patient was diagnosed. All cancer types relevant to children and adults aged less than 40 years old are included. Educational modules provide additional insight on the associations between each cancer and genetic syndromes.
PedMed
Read full descriptionHide full description
From the creators of PedMed.org, the website developed in 2013, comes the new PedMed app for iOS. The PedMed website was developed to provide a quick reference of pediatric and neonatal drug dosages for healthcare providers. The new iOS app provides offline access and a user-friendly interface, ensuring accurate information at your fingertips. Designed for both iOS and computers, PedMed offers seamless access to a comprehensive drug database for infants and children. The drug monographs and practice recommendations reflect the current practices at a tertiary children’s hospital. Drug information evolves constantly as a result of ongoing research and clinical experience. PedMed is updated as new treatments and information become available. It provides a quick reference for healthcare providers working with infants and children and includes citations and links to other resources. Download the PedMed iOS app now and experience the convenience of having up-to-date drug dosing information for neonates and children whenever and wherever you need it. Access 3 individual drugs per day or pay the cheap yearly subscription price for full access and to help fund development for the app and website. For more information, please see Apple's Standard End User License Agreement: [https://www.apple.com/legal/internet-services/itunes/dev/stdeula/] Medical Disclaimer: The PedMed app is a resource for healthcare professionals familiar with pediatric treatment and provides information on pediatric and neonatal drug dosages. Please remember that this app is designed for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a physician or other qualified healthcare provider for any questions or concerns about a medical condition. Relying solely on information from this app without seeking professional medical advice is not advised. The drug monographs and practice recommendations contained in this reference reflect the current practices at BC Children’s Hospital, a tertiary care and teaching hospital and may not be suitable for all settings in which children may be treated. Medication information evolves constantly, and every effort has been made to ensure the accuracy of the information, but it is the responsibility of the prescriber to evaluate the recommendation in each situation. Other reverences should be consulted if there is uncertainty. The authors, editors, reviewers, contributors, and publishers cannot be responsible for the any errors, omissions or for how this information is applied to individual patients.
Screenshots
Verdict
The clearest difference is in-app purchases: MIPOGG at none against PedMed's 1. MIPOGG also leads on iOS requirement (14.0 vs 17.6). PedMed's advantage is update cadence (every 2 months vs every 12 months). On price, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. PedMed sells 1 in-app purchase, starting at $1.99 per year. MIPOGG asks for nothing beyond the download.
MIPOGG ships an update every 12 months, PedMed every 2 months. The most recent releases landed on June 7, 2026 and September 21, 2026 respectively.
| Parameter | MIPOGG | PedMed |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 100.0% of reviews | — |
| Update frequency | Every 12 months | Every 2 months — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 14.0 — better | 17.6 |
| Further details — not scored | ||
| Size | 22 MB | 9 MB |
| Age rating | 17+ | 17+ |
| Developer | CG-MED Inc. | James Greatorex |
In-app purchases
MIPOGG
No in-app purchases
PedMed
- Annual Premium Access$1.991 Year









